Cross-Study Search and Analysis of Pre-clinical Safety Data

Certara’s D360 enables scientists to focus on uncovering trends in their data, without the pain of figuring out how to access it.

A global top 10 pharmaceutical company, devoted to discovering new medicines and new technologies for managing personal health, engaged in an initiative to better address cross-study analysis of pre-clinical safety data.

Toxicologists, pathologists, and pre-clinical study directors regularly examined safety data to investigate data trends across multiple studies, draw correlations between results and exposure, and design future studies but were frustrated by the inability to effectively access and analyze the data according to their individual needs.

Learn More
LinkedIn